BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37243204)

  • 1. GRP78 Inhibitor YUM70 Suppresses SARS-CoV-2 Viral Entry, Spike Protein Production and Ameliorates Lung Damage.
    Ha DP; Shin WJ; Hernandez JC; Neamati N; Dubeau L; Machida K; Lee AS
    Viruses; 2023 May; 15(5):. PubMed ID: 37243204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection.
    Carlos AJ; Ha DP; Yeh DW; Van Krieken R; Tseng CC; Zhang P; Gill P; Machida K; Lee AS
    J Biol Chem; 2021; 296():100759. PubMed ID: 33965375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Hydroxyquinoline Analogue YUM70 Inhibits GRP78 to Induce ER Stress-Mediated Apoptosis in Pancreatic Cancer.
    Samanta S; Yang S; Debnath B; Xue D; Kuang Y; Ramkumar K; Lee AS; Ljungman M; Neamati N
    Cancer Res; 2021 Apr; 81(7):1883-1895. PubMed ID: 33531374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE2-independent SARS-CoV-2 virus entry through cell surface GRP78 on monocytes - evidence from a translational clinical and experimental approach.
    Han B; Lv Y; Moser D; Zhou X; Woehrle T; Han L; Osterman A; Rudelius M; Choukér A; Lei P
    EBioMedicine; 2023 Dec; 98():104869. PubMed ID: 37967509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a druggable site on GRP78 at the GRP78-SARS-CoV-2 interface and virtual screening of compounds to disrupt that interface.
    Lazou M; Hutton JR; Chakravarty A; Joseph-McCarthy D
    J Comput Aided Mol Des; 2024 Jan; 38(1):6. PubMed ID: 38263499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible Involvement of Adipose Tissue in Patients With Older Age, Obesity, and Diabetes With SARS-CoV-2 Infection (COVID-19) via GRP78 (BIP/HSPA5): Significance of Hyperinsulinemia Management in COVID-19.
    Shin J; Toyoda S; Nishitani S; Fukuhara A; Kita S; Otsuki M; Shimomura I
    Diabetes; 2021 Dec; 70(12):2745-2755. PubMed ID: 34615619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AR12 (OSU-03012) suppresses GRP78 expression and inhibits SARS-CoV-2 replication.
    Rayner JO; Roberts RA; Kim J; Poklepovic A; Roberts JL; Booth L; Dent P
    Biochem Pharmacol; 2020 Dec; 182():114227. PubMed ID: 32966814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression and
    Aguiar JA; Tremblay BJ; Mansfield MJ; Woody O; Lobb B; Banerjee A; Chandiramohan A; Tiessen N; Cao Q; Dvorkin-Gheva A; Revill S; Miller MS; Carlsten C; Organ L; Joseph C; John A; Hanson P; Austin RC; McManus BM; Jenkins G; Mossman K; Ask K; Doxey AC; Hirota JA
    Eur Respir J; 2020 Sep; 56(3):. PubMed ID: 32675206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization.
    Kim Y; Gaudreault NN; Meekins DA; Perera KD; Bold D; Trujillo JD; Morozov I; McDowell CD; Chang KO; Richt JA
    Microbiol Spectr; 2022 Jun; 10(3):e0178921. PubMed ID: 35638818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Coronavirus Entry
    Outlaw VK; Bovier FT; Mears MC; Cajimat MN; Zhu Y; Lin MJ; Addetia A; Lieberman NAP; Peddu V; Xie X; Shi PY; Greninger AL; Gellman SH; Bente DA; Moscona A; Porotto M
    mBio; 2020 Oct; 11(5):. PubMed ID: 33082259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Integral Membrane Protein ZMPSTE24 Protects Cells from SARS-CoV-2 Spike-Mediated Pseudovirus Infection and Syncytia Formation.
    Shilagardi K; Spear ED; Abraham R; Griffin DE; Michaelis S
    mBio; 2022 Oct; 13(5):e0254322. PubMed ID: 36197088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thapsigargin and Tunicamycin Block SARS-CoV-2 Entry into Host Cells via Differential Modulation of Unfolded Protein Response (UPR), AKT Signaling, and Apoptosis.
    Al Otaibi A; Al Shaikh Mubarak S; Al Hejji F; Almasaud A; Al Jami H; Iqbal J; Al Qarni A; Harbi NKA; Bakillah A
    Cells; 2024 Apr; 13(9):. PubMed ID: 38727305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of head and neck cancer cell survival and cisplatin resistance by GRP78 small molecule inhibitor YUM70.
    Yamamoto V; Wang B; Lee AS
    Front Oncol; 2022; 12():1044699. PubMed ID: 36713577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumocytes are distinguished by highly elevated expression of the ER stress biomarker GRP78, a co-receptor for SARS-CoV-2, in COVID-19 autopsies.
    Puzyrenko A; Jacobs ER; Sun Y; Felix JC; Sheinin Y; Ge L; Lai S; Dai Q; Gantner BN; Nanchal R; North PE; Simpson PM; Rui H; Benjamin IJ
    Cell Stress Chaperones; 2021 Sep; 26(5):859-868. PubMed ID: 34382151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peimine inhibits variants of SARS-CoV-2 cell entry via blocking the interaction between viral spike protein and ACE2.
    Wang WJ; Chen Y; Su WC; Liu YY; Shen WJ; Chang WC; Huang ST; Lin CW; Wang YC; Yang CS; Hou MH; Chou YC; Wu YC; Wang SC; Hung MC
    J Food Biochem; 2022 Oct; 46(10):e14354. PubMed ID: 35894128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle.
    Mondal T; Shivange G; Habieb A; Tushir-Singh J
    Microbiol Spectr; 2022 Feb; 10(1):e0236421. PubMed ID: 35138160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myxobacterial depsipeptide chondramides interrupt SARS-CoV-2 entry by targeting its broad, cell tropic spike protein.
    Fernandez RA; Quimque MT; Notarte KI; Manzano JA; Pilapil DY; de Leon VN; San Jose JJ; Villalobos O; Muralidharan NH; Gromiha MM; Brogi S; Macabeo APG
    J Biomol Struct Dyn; 2022; 40(22):12209-12220. PubMed ID: 34463219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion.
    Ren W; Ju X; Gong M; Lan J; Yu Y; Long Q; Kenney DJ; O'Connell AK; Zhang Y; Zhong J; Zhong G; Douam F; Wang X; Huang A; Zhang R; Ding Q
    mBio; 2022 Apr; 13(2):e0009922. PubMed ID: 35266815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withanone from
    Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
    Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.